{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:21:24Z","timestamp":1772119284662,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-023-07017-5","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T14:03:07Z","timestamp":1682431387000},"page":"255-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of pregnancy rates in antagonist cycles after luteal support with GnRH-agonist versus progesterone: prospective randomized study"],"prefix":"10.1007","volume":"308","clinical-trial-number":[{"clinical-trial-number":"nct05484193","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5921-1185","authenticated-orcid":false,"given":"Eadit","family":"Buhbut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinad","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilad","family":"Avigdor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ido","family":"Ben-Ami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"7017_CR1","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1210\/jc.2002-021953","volume":"88","author":"NGM Beckers","year":"2003","unstructured":"Beckers NGM, Macklon NS, Eijkemans MJ et al (2003) Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and gnrh antagonist cotreatment. J Clin Endocrinol Metab 88:4186\u20134192. https:\/\/doi.org\/10.1210\/jc.2002-021953","journal-title":"J Clin Endocrinol Metab"},{"key":"7017_CR2","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1093\/humrep\/17.9.2287","volume":"17","author":"EA Pritts","year":"2002","unstructured":"Pritts EA, Atwood AK (2002) Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 17(9):2287\u20132299. https:\/\/doi.org\/10.1093\/humrep\/17.9.2287","journal-title":"Hum Reprod"},{"key":"7017_CR3","doi-asserted-by":"publisher","first-page":"CD009154","DOI":"10.1002\/14651858.CD009154.pub3","volume":"2015","author":"M van der Linden","year":"2015","unstructured":"van der Linden M, Buckingham K, Farquhar C et al (2015) Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 2015(7):CD009154. https:\/\/doi.org\/10.1002\/14651858.CD009154.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"7017_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/oxfordjournals.humrep.a137031","volume":"5","author":"A Golan\u2019","year":"1990","unstructured":"Golan\u2019 A, Ron-El R, Herman A et al (1990) Fetal outcome following inadvertent administration of long-acting DTRP 6 GnRH microcapsules during pregnancy: a case report. Hum Reprod 5(1):123\u2013124. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a137031","journal-title":"Hum Reprod"},{"issue":"4","key":"7017_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/oxfordjournals.humrep.a137112","volume":"5","author":"PJ Isherwood","year":"1990","unstructured":"Isherwood PJ, Ibrahim ZHZ, Matson PL et al (1990) Endocrine changes in women conceiving during treatment with an LHRH agonist. Hum Reprod 5(4):409\u2013412. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a137112","journal-title":"Hum Reprod"},{"key":"7017_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a137830","author":"AE Jackson","year":"1992","unstructured":"Jackson AE, Curtis P, Amso N, Shaw RW (1992) Exposure to LHRH agonists in early pregnancy following the commencement of mid-luteal buserelin for IVF stimulation. Human Reprod. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a137830","journal-title":"Human Reprod"},{"key":"7017_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)57557-8","author":"E Elefant","year":"1995","unstructured":"Elefant E, Biour B, Blumberg-Tick J et al (1995) Administration of a gonadotropin-releasing hormone agonist during pregnancy: follow-up of 28 pregnancies exposed to triptoreline. Fertil Steril. https:\/\/doi.org\/10.1016\/S0015-0282(16)57557-8","journal-title":"Fertil Steril"},{"key":"7017_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a138210","author":"J Balasch","year":"1993","unstructured":"Balasch J, Martinez F, Jove I et al (1993) Inadvertent gonadotrophin-releasing hormone agonist (GiiRHa) administration in the luteal phase may improve fecundity in in-vitro fertilization patients. Human Reprod. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a138210","journal-title":"Human Reprod"},{"key":"7017_CR9","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S0015-0282(16)56396-1","volume":"60","author":"GB Wilshire","year":"1993","unstructured":"Wilshire GB, Emmi AM, Gagliardi CC, Weiss G (1993) Gonadotropin-releasing hormone agonist administration in early human pregnancy is associated with normal outcomes. Fertil Steril 60:980\u2013983. https:\/\/doi.org\/10.1016\/S0015-0282(16)56396-1","journal-title":"Fertil Steril"},{"key":"7017_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a138079","author":"A Weissman","year":"1993","unstructured":"Weissman A, Shoham Z (1993) Favourable pregnancy outcome after administration of a long-acting gonadotrophin-releasing hormone agonist in the mid-luteal phase. Human Reprod. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a138079","journal-title":"Human Reprod"},{"key":"7017_CR11","first-page":"587","volume":"81","author":"DC Young","year":"1993","unstructured":"Young DC, Snabes MC, Poindexter AN (1993) GnRH agonist exposure during the first trimester of pregnancy. Obstet Gynecol 81:587\u2013589","journal-title":"Obstet Gynecol"},{"key":"7017_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0301-2115(98)00109-2","volume":"80","author":"D Chardonnens","year":"1998","unstructured":"Chardonnens D, Sylvan K, Walker D et al (1998) Triptorelin acetate administration in early pregnancy: case reports and review of the literature. Eur J Obst Gynecol Reprod Biol 80:143\u2013149. https:\/\/doi.org\/10.1016\/S0301-2115(98)00109-2","journal-title":"Eur J Obst Gynecol Reprod Biol"},{"key":"7017_CR13","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1093\/HUMREP\/12.11.2557","volume":"12","author":"B Gartner","year":"1997","unstructured":"Gartner B, Moreno C, Marinaro A et al (1997) Case Report: Accidental exposure to daily long-acting gonadotrophinreleasing hormone analogue administration and pregnancy in an in-vitro fertilization cycle. Hum Reprod 12:2557\u20132559. https:\/\/doi.org\/10.1093\/HUMREP\/12.11.2557","journal-title":"Hum Reprod"},{"key":"7017_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/OXFORDJOURNALS.HUMREP.A137324","volume":"6","author":"J Smitz","year":"1991","unstructured":"Smitz J, Camus M, Devroey P et al (1991) CLINICAL REPORTThe influence of inadvertent intranasal buserelin administration in early pregnancy. Hum Reprod 6:290\u2013293. https:\/\/doi.org\/10.1093\/OXFORDJOURNALS.HUMREP.A137324","journal-title":"Hum Reprod"},{"key":"7017_CR15","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/humrep\/deh235","volume":"19","author":"J Tesarik","year":"2004","unstructured":"Tesarik J, Hazout A, Mendoza C (2004) Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Hum Reprod 19:1176\u20131180. https:\/\/doi.org\/10.1093\/humrep\/deh235","journal-title":"Hum Reprod"},{"key":"7017_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FENDO.2022.802688","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wu Y, Pan Z et al (2022) Single-dose versus multiple-dose gnrh agonist for luteal-phase support in women undergoing IVF\/ICSI cycles: a network meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne) 13:1. https:\/\/doi.org\/10.3389\/FENDO.2022.802688","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7017_CR17","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1093\/humrep\/del173","volume":"21","author":"J Tesarik","year":"2006","unstructured":"Tesarik J, Hazout A, Mendoza-Tesarik R et al (2006) Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Hum Reprod 21:2572\u20132579. https:\/\/doi.org\/10.1093\/humrep\/del173","journal-title":"Hum Reprod"},{"key":"7017_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009154.pub3","author":"K Jam","year":"2016","unstructured":"Jam K, van der LindenM MM (2016) Luteal phase support for assisted reproduction cycles (Review) van der Luteal phase support for assisted reproduction cycles (Review). Cochrane Lib Coch Datab Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD009154.pub3","journal-title":"Cochrane Lib Coch Datab Syst Rev"},{"key":"7017_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-8-107","author":"JBA Oliveira","year":"2010","unstructured":"Oliveira JBA, Baruffi R, Petersen CG et al (2010) Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis. Reprod Biol Endocrinol. https:\/\/doi.org\/10.1186\/1477-7827-8-107","journal-title":"Reprod Biol Endocrinol"},{"key":"7017_CR20","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1093\/humrep\/deh830","volume":"20","author":"C Pirard","year":"2005","unstructured":"Pirard C, Donnez J, Loumaye E (2005) GnRH agonist as novel luteal support: Results of a randomized, parallel group, feasibility study using intranasal administration of buserelin. Hum Reprod 20:1798\u20131804. https:\/\/doi.org\/10.1093\/humrep\/deh830","journal-title":"Hum Reprod"},{"key":"7017_CR21","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1093\/humrep\/del072","volume":"21","author":"C Pirard","year":"2006","unstructured":"Pirard C, Donnez J, Loumaye E (2006) GnRH agonist as luteal phase support in assisted reproduction technique cycles: Results of a pilot study. Hum Reprod 21:1894\u20131900. https:\/\/doi.org\/10.1093\/humrep\/del072","journal-title":"Hum Reprod"},{"key":"7017_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/727569","author":"C Pirard","year":"2015","unstructured":"Pirard C, Loumaye E, Laurent P, Wyns C (2015) Contribution to more patient-friendly art treatment: Efficacy of continuous low-dose GnRH agonist as the only luteal support\u2014Results of a prospective, randomized, comparative study. Int J Endocrinol. https:\/\/doi.org\/10.1155\/2015\/727569","journal-title":"Int J Endocrinol"},{"key":"7017_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/J.FERTNSTERT.2016.10.011","volume":"107","author":"I Bar Hava","year":"2017","unstructured":"Bar Hava I, Blueshtein M, Ganer Herman H et al (2017) Gonadotropin-releasing hormone analogue as sole luteal support in antagonist-based assisted reproductive technology cycles. Fertil Steril 107:130-135.e1. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2016.10.011","journal-title":"Fertil Steril"},{"key":"7017_CR24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5935\/1518-0557.20200077","volume":"25","author":"S Salehpour","year":"2021","unstructured":"Salehpour S, Nazari L, Hosseini S et al (2021) Efficacy of daily GnRH agonist for luteal phase support following GnRH agonist triggered ICSI cycles versus conventional strategy: a randomized controlled trial. JBRA Assist Reprod 25:368\u2013372. https:\/\/doi.org\/10.5935\/1518-0557.20200077","journal-title":"JBRA Assist Reprod"},{"key":"7017_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0175985","author":"R Wang","year":"2017","unstructured":"Wang R, Lin S, Wang Y et al (2017) Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: a systematic review and meta-analysis. PLoS ONE. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0175985","journal-title":"PLoS ONE"},{"key":"7017_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/S12958-021-00814-0","author":"J Yang","year":"2021","unstructured":"Yang J, Zhang X, Ding X et al (2021) Cumulative live birth rates between GnRH-agonist long and GnRH-antagonist protocol in one ART cycle when all embryos transferred: real-word data of 18,853 women from China. Reprod Biol Endocrinol. https:\/\/doi.org\/10.1186\/S12958-021-00814-0","journal-title":"Reprod Biol Endocrinol"},{"key":"7017_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/AJI.12473","volume":"75","author":"AS Bhurke","year":"2016","unstructured":"Bhurke AS, Bagchi IC, Bagchi MK (2016) Progesterone-regulated endometrial factors controlling implantation. Am J Reprod Immunol 75:237\u2013245. https:\/\/doi.org\/10.1111\/AJI.12473","journal-title":"Am J Reprod Immunol"},{"key":"7017_CR28","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/J.FERTNSTERT.2016.04.004","volume":"106","author":"I Bar-Hava","year":"2016","unstructured":"Bar-Hava I, Mizrachi Y, Karfunkel-Doron D et al (2016) Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders. Fertil Steril 106:330\u2013333. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2016.04.004","journal-title":"Fertil Steril"},{"key":"7017_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/FENDO.2017.00124\/BIBTEX","volume":"8","author":"A Benmachiche","year":"2017","unstructured":"Benmachiche A, Benbouhedja S, Zoghmar A et al (2017) Impact of mid-luteal phase GnRH agonist administration on reproductive outcomes in GnRH agonist-triggered cycles: a randomized controlled trial. Front Endocrinol (Lausanne) 8:124. https:\/\/doi.org\/10.3389\/FENDO.2017.00124\/BIBTEX","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7017_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/J.EJOGRB.2014.08.026","volume":"182","author":"GA Yildiz","year":"2014","unstructured":"Yildiz GA, \u015e\u00fck\u00fcr YE, Ate\u015f C, Ayta\u00e7 R (2014) The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: A randomized clinical trial. Eur J Obst Gynecol Reprod Biol 182:66\u201370. https:\/\/doi.org\/10.1016\/J.EJOGRB.2014.08.026","journal-title":"Eur J Obst Gynecol Reprod Biol"},{"key":"7017_CR31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1080\/09513590.2018.1548591","volume":"35","author":"S Friedler","year":"2019","unstructured":"Friedler S, Grin L (2019) Luteal phase support with GnRH agonist does not eliminate the risk for ovarian hyperstimulation syndrome. Gynecol Endocrinol 35:368\u2013369. https:\/\/doi.org\/10.1080\/09513590.2018.1548591","journal-title":"Gynecol Endocrinol"},{"key":"7017_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/HUMUPD\/DMV059","volume":"22","author":"R Maggi","year":"2020","unstructured":"Maggi R, Cariboni AM, Marelli MM et al (2020) GnRH and GnRH receptors in the pathophysiology of the human female reproductive system. Hum Reprod Update 22:358\u2013381. https:\/\/doi.org\/10.1093\/HUMUPD\/DMV059","journal-title":"Hum Reprod Update"},{"key":"7017_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/1464727012000199351","volume":"4","author":"S Marcus","year":"2001","unstructured":"Marcus S, Ledger W (2001) Efficacy and safety of long-acting GnRH agonists in in vitro fertilization and embryo transfer. Hum Fertil 4:85\u201393","journal-title":"Hum Fertil"},{"key":"7017_CR34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198807283190401","author":"AJ Wilcox","year":"2010","unstructured":"Wilcox AJ, Weinberg CR, O\u2019Connor JF et al (2010) Incidence of early loss of pregnancy. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJM198807283190401","journal-title":"N Engl J Med"},{"key":"7017_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-90-481-9485-8_20","volume":"686","author":"H Dolk","year":"2010","unstructured":"Dolk H, Loane M, Garne E (2010) The prevalence of congenital anomalies in europe. Adv Exp Med Biol 686:349\u2013364. https:\/\/doi.org\/10.1007\/978-90-481-9485-8_20","journal-title":"Adv Exp Med Biol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-07017-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-023-07017-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-07017-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T08:08:42Z","timestamp":1684310922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-023-07017-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["7017"],"URL":"https:\/\/doi.org\/10.1007\/s00404-023-07017-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2404722\/v1","asserted-by":"object"}]},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"22 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shaare Zedek Medical Center (Date: May 11, 2020\/ number: 0026-20-SZMC).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}